Image of Azithromycin for acute lower respiratory tract infections (Review)

LITERATURE

Azithromycin for acute lower respiratory tract infections (Review)


Acute lower respiratory tract infections (LRTI) range from acute bronchitis and acute exacerbations of chronic bronchitis to pneumonia.
Approximately five million people die from acute respiratory tract infections annually. Among these, pneumonia represents the most
frequent cause of mortality, hospitalisation and medical consultation. Azithromycin is a macrolide antibiotic, structurally modified from
erythromycin and noted for its activity against some gram-negative organisms associated with respiratory tract infections, particularly
Haemophilus influenzae (H. influenzae)


Availability

Iztron-010Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD001954.
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous